Beyond the Pandemic: The Value of Antimicrobial Stewardship.
作者信息
Kanj Souha S, Ramirez Paula, Rodrigues Camilla
机构信息
Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon.
Critical Care Department, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
出版信息
Front Public Health. 2022 Jun 27;10:902835. doi: 10.3389/fpubh.2022.902835. eCollection 2022.
Abstract
摘要
相似文献
1
Beyond the Pandemic: The Value of Antimicrobial Stewardship.疫情之外：抗菌药物管理的价值
Front Public Health. 2022 Jun 27;10:902835. doi: 10.3389/fpubh.2022.902835. eCollection 2022.
2
Antimicrobial stewardship: a COVID casualty?抗菌药物管理：新冠疫情的牺牲品？
J Hosp Infect. 2020 Nov;106(3):401-403. doi: 10.1016/j.jhin.2020.10.002. Epub 2020 Oct 9.
3
Antimicrobial Stewardship (AMS) During COVID-19: Eyes and Ears on the AMS Team.COVID-19 期间的抗菌药物管理（AMS）：AMS 团队的眼睛和耳朵。
Stud Health Technol Inform. 2023 Jun 22;304:62-66. doi: 10.3233/SHTI230370.
4
Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.新冠疫情期间纽约市一家医院的抗菌药物管理视角：挑战与机遇。
Am J Health Syst Pharm. 2021 Mar 31;78(8):743-750. doi: 10.1093/ajhp/zxaa419.
5
[Antimicrobial stewardship program during the COVID-19 pandemic].[新冠疫情期间的抗菌药物管理计划]
Medicina (B Aires). 2022;82(5):641-646.
6
Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.2020 年日本的抗菌药物使用量大幅下降——新冠疫情可能发挥了作用。
Int J Infect Dis. 2022 Jun;119:13-17. doi: 10.1016/j.ijid.2022.03.019. Epub 2022 Mar 17.
7
Dedicated time for antimicrobial stewardship-How much and why? Lessons learned from South Korea.专注于抗菌药物管理的时间——需要多少，为什么？来自韩国的经验教训。
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1436-1437. doi: 10.1017/ice.2020.1235.
8
Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach.抗微生物药物耐药性：抗微生物药物/诊断管理与感染预防方法。
Med Clin North Am. 2018 Sep;102(5):819-829. doi: 10.1016/j.mcna.2018.04.005. Epub 2018 Jun 27.
9
The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.贝鲁特一家三级保健中心在 COVID-19 大流行期间实施抗菌药物管理项目的经验以及抗生素使用和耐药趋势
J Infect Public Health. 2024 Feb;17(2):254-262. doi: 10.1016/j.jiph.2023.12.007. Epub 2023 Dec 14.
10
Impact of the COVID-19 pandemic on provision of antimicrobial stewardship education and training in UK health service sites.2019年冠状病毒病大流行对英国医疗服务机构抗菌药物管理教育与培训提供情况的影响
J Interprof Care. 2023 May-Jun;37(3):519-521. doi: 10.1080/13561820.2022.2082393. Epub 2022 Jul 27.
引用本文的文献
1
Implementation of Antimicrobial Stewardship Programs in Saudi Arabia: A Systematic Review.沙特阿拉伯抗菌药物管理计划的实施：一项系统综述
Microorganisms. 2025 Feb 17;13(2):440. doi: 10.3390/microorganisms13020440.
2
Knowledge, awareness and practices of healthcare workers regarding antimicrobial use, resistance and stewardship in Zambia: a multi-facility cross-sectional study.赞比亚医护人员在抗菌药物使用、耐药性及管理方面的知识、意识与实践：一项多机构横断面研究
JAC Antimicrob Resist. 2024 May 17;6(3):dlae076. doi: 10.1093/jacamr/dlae076. eCollection 2024 Jun.
3
Protocols, policies and practices for antimicrobial stewardship in hospitalized patients in least-developed and low-income countries: a systematic review.在最不发达国家和低收入国家住院患者中实施抗菌药物管理的方案、政策和实践：系统评价。
Antimicrob Resist Infect Control. 2023 Nov 23;12(1):131. doi: 10.1186/s13756-023-01335-8.
4
Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.抗生素耐药性与新冠疫情：低收入和中等收入国家面临的双重危机及复杂挑战
Health Sci Rep. 2023 Sep 13;6(9):e1566. doi: 10.1002/hsr2.1566. eCollection 2023 Sep.
5
The Impact of COVID-19 on the Epidemiology and Outcomes of Candidemia: A Retrospective Study from a Tertiary Care Center in Lebanon.新型冠状病毒肺炎对念珠菌血症流行病学及转归的影响：黎巴嫩一家三级医疗中心的回顾性研究
J Fungi (Basel). 2023 Jul 21;9(7):769. doi: 10.3390/jof9070769.
本文引用的文献
1
Coronavirus disease 2019 (COVID-19) oral antivirals stewardship: Establishing game rules.2019冠状病毒病（COVID-19）口服抗病毒药物管理：制定游戏规则。
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1990-1992. doi: 10.1017/ice.2022.25. Epub 2022 Feb 4.
2
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.COVID-19 与抗菌药物管理：经验教训、最佳实践和未来影响。
Int J Infect Dis. 2021 Dec;113:103-108. doi: 10.1016/j.ijid.2021.10.001. Epub 2021 Oct 5.
3
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.新冠疫情对抗菌药物耐药性监测、预防和控制的影响：全球调查。
J Antimicrob Chemother. 2021 Oct 11;76(11):3045-3058. doi: 10.1093/jac/dkab300.
4
Laboratory Readiness and Response for SARS-Cov-2 in Indonesia.印度尼西亚针对 SARS-CoV-2 的实验室准备和应对。
Front Public Health. 2021 Jul 19;9:705031. doi: 10.3389/fpubh.2021.705031. eCollection 2021.
5
Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns.COVID-19 时期 ICU 中的抗菌药物管理：已知的未知。
Int J Antimicrob Agents. 2021 Oct;58(4):106409. doi: 10.1016/j.ijantimicag.2021.106409. Epub 2021 Jul 30.
6
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.2019年冠状病毒病大流行对全球抗菌药物和消毒剂耐药性的潜在影响：抗菌药物耐药性洞察全球视角
JAC Antimicrob Resist. 2021 Apr 8;3(2):dlab038. doi: 10.1093/jacamr/dlab038. eCollection 2021 Jun.
7
Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience.住院COVID-19患者的继发性感染：印度经验
Infect Drug Resist. 2021 May 24;14:1893-1903. doi: 10.2147/IDR.S299774. eCollection 2021.
8
Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者的呼吸机相关性肺炎：一项系统评价和荟萃分析
Antibiotics (Basel). 2021 May 7;10(5):545. doi: 10.3390/antibiotics10050545.
9
Emergence of in Brazil in a COVID-19 Intensive Care Unit.在巴西一家新冠肺炎重症监护病房中的[具体事物]出现。 （你提供的原文“Emergence of in Brazil in a COVID-19 Intensive Care Unit.”中“of”后面缺少具体内容，我按字面意思尽量完整翻译了）
J Fungi (Basel). 2021 Mar 17;7(3):220. doi: 10.3390/jof7030220.
10
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.新冠疫情对抗菌药物耐药性出现的影响：调整对未来疫情的应对措施。
Life (Basel). 2021 Mar 10;11(3):220. doi: 10.3390/life11030220.
Zotero 插件